

Psychedelics Today
Psychedelics Today
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
Episodes
Mentioned books

Nov 5, 2024 • 46min
PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy
In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it's legal) to employees. She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an employee of a company Enthea works with, and the importance of evidence-based medical policy and rigorous screening to make sure people are getting the best intervention possible. One of Enthea's largest clients is Dr. Bronner's, who reported incredible improvements after employees used the benefit, with a 65% improvement in depression scores and an 86% improvement in PTSD. She also discusses: How psychedelics bring awareness to what we need to work on Less-discussed treatment modalities, like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and stellate ganglion block (SGB) The inefficiency of traditional talk therapy: 50% of people only see really good benefits after 20 sessions The importance of viewing mental health as individualized care: What else can we offer to people who haven't been helped by traditional methods? The research that she wants to see, like measures in how present or productive people are before and after experiences and more! For links, head to the show notes page.

Nov 1, 2024 • 55min
PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller
Joe and Kyle reintroduce their series by discussing Massachusetts' pivotal Question 4 on psychedelic legalization. They dive into the bill's supporters and opposition, including actress Eliza Dushku advocating for psychedelic facilitation after her own transformative experience. The duo explores psilocybin's therapeutic potential for chronic pain and the importance of experiential approaches in psychedelic research. They also reflect on the fusion of psychedelics, philosophy, and technology, emphasizing the need for a deeper understanding of consciousness.

Oct 29, 2024 • 1h 2min
PT560 – Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?, with Dr. Peter Sjöstedt-Hughes
Dr. Peter Sjöstedt-Hughes, a philosopher and lecturer at the University of Exeter, dives into the profound connections between philosophy and psychedelics. He reveals how William James influenced his exploration of metaphysics, emphasizing its importance for meaningful psychedelic experiences. The discussion touches on panpsychism, ethics in psychedelic research, and the limitations of scientific materialism. Sjöstedt-Hughes advocates for a philosophical approach to understanding consciousness, which could reshape our interactions with non-ordinary states.

Oct 25, 2024 • 41min
PT559 – The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections, with Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, and Michael Baime, MD
In this discussion, Taylor Andrews Flatt, a pediatric nurse practitioner and co-founder of the Penn Psychedelics Collaborative, along with Victor Pablo Acero, a researcher on psychedelics, Jackie Tileston, a fine arts professor, and Michael Baime, director of mindfulness programs, converge in an enlightening conversation. They explore psychedelics' role in enhancing health beyond treatment, delve into the concept of psychoactive art, and share cutting-edge research, including using salvia for stroke recovery. Their collaborative insights highlight the power of interdisciplinary approaches in advancing psychedelic science.

Oct 22, 2024 • 1h 14min
PT558 – What You Need to Know About Massachusetts' Question 4 and the Natural Psychedelic Substances Act, with Graham Moore and Jamie Morey
Graham Moore, an advocate for the Massachusetts Natural Psychedelic Substances Act, shares his personal battle with OCD and how psilocybin transformed his life. Jamie Morey, the Community Engagement Director, discusses her advocacy rooted in family mental health struggles. They dive into Massachusetts’ initiative to decriminalize psychedelics, the hurdles faced in public support, and the need for informed discussions on mental health alternatives. Their compelling stories highlight the potential of psychedelics in healing, especially for veterans and those facing addiction.

Oct 18, 2024 • 1h 12min
PT557 – Psychedelic Education Through a Healing Justice Lens, with Diana Quinn, ND
Diana Quinn, a naturopathic doctor and healing justice practitioner, shares her journey into psychedelic education at the Naropa Center for Psychedelic Studies. She highlights the importance of equity and accessibility in training programs while emphasizing the need to respect cultural plant traditions. The conversation delves into the challenges of integrating non-ordinary states within Western frameworks and the impact of colonialism on healing practices. Diana also encourages an anti-capitalist perspective on using psychedelics in a world fraught with systemic injustices.

Oct 15, 2024 • 1h 13min
PT556 – The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos?, with Rick Doblin, Ph.D.
Rick Doblin, Ph.D., is the founder of MAPS and a pioneer in psychedelic research. In this discussion, he shares insights on the FDA's handling of MDMA trials, emphasizing miscommunications that led to setbacks for Lykos Therapeutics. Doblin argues that neglecting public perception was a critical mistake and explores the bias at the FDA. He also highlights the need for better public education and drug policy reform, contrasting U.S. and European regulatory approaches while discussing innovative international MDMA therapy initiatives.

Oct 11, 2024 • 1h 16min
PT555 – Protecting Indigenous Wisdom: Rethinking Psychedelic Legalization, with Gabriela Galindo
Gabriela Galindo, program coordinator of FLOWS, champions Indigenous rights in the psychedelic conversation. She highlights the importance of respecting each plant's cultural history and argues for Indigenous communities' consent in legislative decisions. Galindo prefers the term 'movement' over 'renaissance' when discussing psychedelics. She reflects on how climate crises demand insights from Indigenous harmony with nature while navigating the delicate balance between decriminalization and cultural preservation in psychedelic practices.

67 snips
Oct 8, 2024 • 1h 7min
PT554 – The Hero's Journey: Finding Your Story in Psychedelic Healing, with Mareesa Stertz
Mareesa Stertz, a filmmaker and co-founder of Lucid News, dives into her personal journey of healing through psychedelics. She shares insights from her seven ayahuasca trips, revealing how she discovered the impact of 'little t' traumas. Mareesa discusses the Hero’s Journey as a method for self-awareness and the importance of storytelling in healing. She also introduces her artistic projects, including immersive Sphinx installations for Burning Man, aimed at fostering deep connections and meaningful experiences.

Oct 4, 2024 • 1h 12min
PT553 – Healing Psychedelics: Where Science Meets Spirit, with Micah Stover & Craig Heacock, MD
Micah Stover, a certified psychedelic somatic therapist and author, shares her transformative journey inspired by ancestral voices and healing through psychedelics. Craig Heacock, an addiction psychiatrist and podcast host, discusses the intersection of modern psychology and indigenous healing. They explore the importance of community and nature in overcoming trauma, and the role of discernment in non-ordinary states of consciousness. Together, they examine how love and connection can enrich therapeutic practices and enhance healing outcomes.


